Improvements in waist circumference, blood pressure, HbA1c, lipid profiles, and overall fitness are important indicators of health progress
Recently, it was demonstrated that the same drug slowed down memory decline in a group of patients with obesity and type 2 diabetes (Vadini et al., 2020) and more recently, GLP1 receptor agonists were shown to prevent glucose transport decline through BBB in AD patients, although no conclusions were drawn on cognitive decline (Gejl et al., 2016)
This article shows how FGF21 regulates systemic energy metabolism
It does this by transporting oxygen to nail beds and hair follicles, which can help with strength and length
Firestein GS, McInnes IB
[11] [12] Extensive clinical experience and published studies have not identified adverse effects in breastfed infants whose mothers take metformin